Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

XBIOXenetic Biosciences, Inc.

Nasdaq · CIK 0001534525
Filer categoryNon-accelerated filer<br>Smaller reporting company
Entity typeoperating
SIC2834 Pharmaceutical Preparations
FY end1231
XBRL facts343

Identity from submissions API

NameXenetic Biosciences, Inc.
CIK0001534525
TickersXBIO
ExchangesNasdaq
Entity typeoperating
CategoryNon-accelerated filer<br>Smaller reporting company
SIC2834 Pharmaceutical Preparations
EIN452952962
LEI—
Fiscal year end1231
State of incorporationNV NV
Phone781-778-7720
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • General Sales & Leasing, Inc. (2013-02-27T05:00:00.000Z → 2014-01-10T05:00:00.000Z)
  • GENERAL AIRCRAFT INC. (2011-11-21T05:00:00.000Z → 2013-02-12T05:00:00.000Z)
Business address
945 CONCORD ST.
FRAMINGHAM
MA
01701
MA
Mailing address
945 CONCORD ST.
FRAMINGHAM
MA
01701
MA

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

488 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-13 DEFA14A DEFA14A 0001683168-26-008651 001-37937 261549212 34 73814
2026-11-13 8-K CURRENT REPORT 2.02,9.01 0001683168-26-008650 001-37937 261549200 34 257838 1 1
2026-11-12 10-Q FORM 10-Q FOR SEP 2026 0001683168-26-008628 001-37937 261547958 34 3022870 1 1
2026-11-12 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001037389-26-000072 005-89709 261546497 34 9567
2026-09-23 8-K CURRENT REPORT 7.01,9.01 0001683168-26-007340 001-37937 261401707 34 6865813 1 1
2026-09-18 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0002103370-26-000003 005-89709 261390459 34 41866
2026-09-16 8-K FORM 8-K 1.01,3.02,7.01,9.01 0001683168-26-007181 001-37937 261382355 34 21201351 1 1
2026-08-07 8-K FORM 8-K 2.02,9.01 0001683168-26-006077 001-37937 261251554 34 228276 1 1
2026-08-06 10-Q FORM 10-Q FOR JUN 2026 0001683168-26-006061 001-37937 261249700 34 2968410 1 1
2026-05-29 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0002103370-26-000001 005-89709 261044236 34 42010
2026-05-14 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001037389-26-000042 005-89709 26979967 34 9562
2026-05-13 8-K FORM 8-K 2.02,9.01 0001683168-26-003766 001-37937 26971003 34 228683 1 1
2026-05-12 10-Q QUARTERLY REPORT FOR MARCH 2026 0001683168-26-003727 001-37937 26969126 34 2438629 1 1
2026-04-24 10-K/A FORM 10-K FOR DEC 2025 AMENDMENT 1 0001683168-26-003207 001-37937 26895713 34 716413 1 1
2026-04-24 8-K CURRENT REPORT 5.02,9.01 0001683168-26-003203 001-37937 26895471 34 231899 1 1
2026-04-23 4 xslF345X06/ownership.xml 0001683168-26-003163 5241
2026-03-13 8-K CURRENT REPORT 2.02,9.01 0001683168-26-001744 001-37937 26750109 34 228034 1 1
2026-03-12 10-K FORM 10-K FOR DEC 2025 0001683168-26-001737 001-37937 26748789 34 6046937 1 1
2026-02-12 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001037389-26-000022 005-89709 26625372 34 9351
2026-01-09 8-K FORM 8-K 8.01 0001683168-26-000196 001-37937 26523784 34 188808 1 1
2026-01-05 4 xslF345X05/ownership.xml 0001683168-26-000104 5487
2026-01-05 4 xslF345X05/ownership.xml 0001683168-26-000103 5436
2026-01-05 4 xslF345X05/ownership.xml 0001683168-26-000102 5416
2026-01-05 4 xslF345X05/ownership.xml 0001683168-26-000101 5442
2025-12-11 DEFA14A ADDITIONAL DEFINITIVE PROXY SOLICITING MATERIALS 0001683168-25-009077 001-37937 251565660 34 32741
2025-12-11 8-K CURRENT REPORT 7.01,9.01 0001683168-25-009076 001-37937 251565655 34 221566 1 1
2025-11-13 8-K CURRENT REPORT 2.02,9.01 0001683168-25-008288 001-37937 251475645 34 226229 1 1
2025-11-12 10-Q FORM 10-Q FOR SEP 2025 0001683168-25-008259 001-37937 251473445 34 2768952 1 1
2025-10-31 ARS ANNUAL REPORT TO SECURITY HOLDERS 0001683168-25-007876 001-37937 251440902 34 1839793
2025-10-31 DEFA14A DEFINITIVE ADDITIONAL MATERIALS 0001683168-25-007873 001-37937 251440794 34 388151
2025-10-31 DEF 14A DEFINITIVE PROXY STATEMENT 0001683168-25-007872 001-37937 251440637 34 1708990 1 1
2025-10-14 8-K CURRENT REPORT 1.01,8.01,9.01 0001683168-25-007528 001-37937 251389934 34 465810 1 1
2025-10-14 424B5 FORM 424B5 0001683168-25-007512 333-282756 251388944 33 458303
2025-10-10 424B5 FORM 424B5 0001683168-25-007488 333-282756 251386492 33 459465
2025-08-13 8-K FORM 8-K 2.02,9.01 0001683168-25-006001 001-37937 251209038 34 225271 1 1
2025-08-12 10-Q FORM 10-Q FOR JUN 2025 0001683168-25-005983 001-37937 251207702 34 2739352 1 1
2025-05-14 8-K FORM 8-K 2.02,9.01 0001683168-25-003513 001-37937 25942771 34 232142 1 1
2025-05-13 10-Q FORM 10-Q FOR MAR 2025 0001683168-25-003496 001-37937 25941114 34 2154622 1 1
2025-05-13 10-K/A AMENDMENT #2 TO FORM 10-K 0001683168-25-003493 001-37937 25940643 34 629672 1 1
2025-04-29 10-K/A AMENDMENT NO. 1 TO FORM 10-K 0001683168-25-002939 001-37937 25888934 34 720539 1 1
2025-04-10 8-K FORM 8-K 4.01,9.01 0001683168-25-002396 001-37937 25826522 34 213409 1 1
2025-03-19 8-K/A AMENDMENT NO 1 9.01 0001683168-25-001712 001-37937 25751790 34 230618 1 1
2025-03-19 8-K CURRENT REPORT 2.02,9.01 0001683168-25-001693 001-37937 25750896 34 233968 1 1
2025-03-18 10-K FORM 10-K FOR DEC 2024 0001683168-25-001686 001-37937 25748876 34 5965592 1 1
2024-12-13 4 xslF345X05/ownership.xml 0001683168-24-008720 5424
2024-12-13 4 xslF345X05/ownership.xml 0001683168-24-008719 5455
2024-12-13 4 xslF345X05/ownership.xml 0001683168-24-008718 5444
2024-12-13 4 xslF345X05/ownership.xml 0001683168-24-008717 5467
2024-12-13 8-K CURRENT REPORT 5.07 0001683168-24-008712 001-37937 241548840 34 237213 1 1
2024-11-13 8-K FORM 8-K 2.02,9.01 0001683168-24-007929 001-37937 241451321 34 230630 1 1
2024-11-12 10-Q FORM 10-Q FOR SEPT 2024 0001683168-24-007903 001-37937 241448888 34 2616917 1 1
2024-11-07 8-K FORM 8-K 1.01,7.01,9.01 0001683168-24-007710 001-37937 241433427 34 229032 1 1
2024-11-01 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2024-11-01 17:00:00 9999999995-24-003345 333-282756 241420512 33 1919
2024-10-31 8-K CURRENT REPORT 5.02 0001683168-24-007527 001-37937 241415965 34 200079 1 1
2024-10-31 ARS ANNUAL REPORT TO SECURITY HOLDERS 0001683168-24-007520 001-37937 241415884 34 1580653
2024-10-31 DEFA14A DEFINITIVE ADDITIONAL MATERIALS 0001683168-24-007518 001-37937 241415797 34 2011180
2024-10-31 DEF 14A DEFINITIVE PROXY 0001683168-24-007517 001-37937 241415690 34 3221403 1 1
2024-10-30 CORRESP filename1.htm 0001683168-24-007475 12384
2024-10-25 UPLOAD filename1.pdf 0000000000-24-011948 333-282756 40305
2024-10-21 S-3 FORM S-3 0001683168-24-007258 333-282756 241384015 33 1789064 1 1
2024-08-14 8-K FORM 8-K 2.02,9.01 0001683168-24-005600 001-37937 241204236 34 257702 1 1
2024-08-13 10-Q QUARTERLY REPORT 0001683168-24-005572 001-37937 241202224 34 2804679 1 1
2024-07-18 25-NSE xslF25X02/primary_doc.xml 0001354457-24-000494 001-37937 241124883 34 3157
2024-06-21 4 xslF345X05/ownership.xml 0001683168-24-004421 5657
2024-06-21 8-K 8-K 5.02 0001683168-24-004415 001-37937 241060925 34 245710 1 1
2024-05-22 8-K FORM 8-K 5.02,7.01,9.01 0001683168-24-003779 001-37937 24974184 34 274295 1 1
2024-05-10 8-K FORM 8-K 2.02,9.01 0001683168-24-003192 001-37937 24932967 34 284881 1 1
2024-05-09 10-Q FORM 10-Q FOR 3-31-24 0001683168-24-003172 001-37937 24931695 34 2353074 1 1
2024-04-26 10-K/A AMENDMENT NO. 1 TO FORM 10-K 0001683168-24-002740 001-37937 24884365 34 279769
2024-03-22 8-K CURRENT REPORT 2.02,9.01 0001683168-24-001606 001-37937 24773120 34 272925 1 1
2024-03-21 10-K FORM 10-K FOR DEC 2023 0001683168-24-001594 001-37937 24772149 34 5967770 1 1
2024-03-18 SC 13D/A AMENDMENT NO. 2 TO SCHEDULE 13D 0001213900-24-023384 005-89709 24758180 34 104646
2024-02-12 8-K FORM 8-K 7.01 0001683168-24-000866 001-37937 24617655 34 242596 1 1
2023-12-18 4 xslF345X05/ownership.xml 0001683168-23-008917 5413
2023-12-18 3 xslF345X02/ownership.xml 0001683168-23-008915 3692
2023-12-13 4 xslF345X05/ownership.xml 0001683168-23-008825 5597
2023-12-13 4 xslF345X05/ownership.xml 0001683168-23-008826 5619
2023-12-13 4 xslF345X05/ownership.xml 0001683168-23-008824 5591
2023-12-08 4 xslF345X05/ownership.xml 0001683168-23-008740 5342
2023-12-08 4 xslF345X05/ownership.xml 0001683168-23-008736 5365
2023-12-08 4 xslF345X05/ownership.xml 0001683168-23-008737 5362
2023-12-08 4 xslF345X05/ownership.xml 0001683168-23-008739 5360
2023-12-08 4 xslF345X05/ownership.xml 0001683168-23-008738 5385
2023-12-08 4 xslF345X05/ownership.xml 0001683168-23-008735 5357
2023-12-08 8-K FORM 8-K 5.07 0001683168-23-008731 001-37937 231476208 34 254664 1 1
2023-11-13 ARS ANNUAL REPORT 0001683168-23-007994 001-37937 231399927 34 1625788
2023-11-13 DEF 14A DEFINITIVE PROXY STATEMENT 0001683168-23-007992 001-37937 231399819 34 1523870 1 1
2023-11-13 8-K CURRENT REPORT 2.02,9.01 0001683168-23-007922 001-37937 231395394 34 272044 1 1
2023-11-09 10-Q QUARTERLY REPORT 0001683168-23-007820 001-37937 231393551 34 2636519 1 1
2023-09-18 SC 13D/A AMENDMENT NO. 1 TO SCHEDULE 13D 0001213900-23-077250 005-89709 231260591 34 112162
2023-08-11 8-K CURRENT REPORT 2.02,9.01 0001683168-23-005538 001-37937 231161596 34 279287 1 1
2023-08-10 10-Q QUARTERLY REPORT 0001683168-23-005513 001-37937 231160052 34 2670860 1 1
2023-06-15 SC 13D SCHEDULE 13D 0001213900-23-049318 005-89709 231018503 34 115984
2023-06-06 8-K CURRENT REPORT 7.01,9.01 0001683168-23-003931 001-37937 23994910 34 5780616 1 1
2023-06-02 8-K FORM 8-K 8.01 0001683168-23-003826 001-37937 23986768 34 241049 1 1
2023-05-12 8-K FORM 8-K 3.03,5.03,7.01,9.01 0001683168-23-003243 001-37937 23914335 34 435376 1 1
2023-05-11 8-K 8-K 2.02,9.01 0001683168-23-003203 001-37937 23911589 34 273993 1 1
2023-05-11 10-Q FORM 10-Q 0001683168-23-003201 001-37937 23911548 34 2472478 1 1
2023-04-28 10-K/A ANNUAL REPORT AMENDMENT 1 0001683168-23-002763 001-37937 23867000 34 273369
2023-03-23 8-K CURRENT REPORT 2.02,9.01 0001683168-23-001681 001-37937 23754469 34 281739 1 1
2023-03-22 10-K FORM 10-K 0001683168-23-001674 001-37937 23753309 34 6964588 1 1
2022-12-22 8-K FORM 8-K 5.07 0001683168-22-008623 001-37937 221482298 34 245701 1 1
2022-12-09 4 xslF345X03/ownership.xml 0001683168-22-008325 5358
2022-12-09 4 xslF345X03/ownership.xml 0001683168-22-008324 5330
2022-12-09 4 xslF345X03/ownership.xml 0001683168-22-008323 5315
2022-12-09 4 xslF345X03/ownership.xml 0001683168-22-008322 5335
2022-12-09 4 xslF345X03/ownership.xml 0001683168-22-008321 5333
2022-12-09 4 xslF345X03/ownership.xml 0001683168-22-008320 5302
2022-12-09 8-K CURRENT REPORT 5.07 0001683168-22-008311 001-37937 221455165 34 253778 1 1
2022-12-02 8-K CURRENT REPORT 3.01 0001683168-22-008170 001-37937 221442836 34 244307 1 1
2022-11-10 8-K FORM 8-K 2.02,9.01 0001683168-22-007476 001-37937 221374881 34 291259 1 1
2022-11-09 10-Q FORM 10-Q 0001683168-22-007447 001-37937 221373148 34 2781893 1 1
2022-10-21 SC 13G SC 13G 0001104659-22-110633 005-89709 221323965 34 70313
2022-10-17 DEFA14A ADDITIONAL DEFINITIVE PROXY SOLICITING MATERIALS 0001683168-22-006927 001-37937 221314212 34 327224
2022-10-17 DEF 14A DEFINITIVE PROXY 0001683168-22-006926 001-37937 221314199 34 581112
2022-10-13 D xslFormDX01/primary_doc.xml 06b 0001200876-22-000032 021-461635 221308761 33 12121
2022-10-12 8-K FORM 8-K 3.02 0001683168-22-006850 001-37937 221307328 34 245789 1 1
2022-10-03 PRE 14A PRELIMINARY PROXY 0001683168-22-006747 001-37937 221288419 34 579937
2022-08-12 8-K FORM 8-K 2.02,9.01 0001683168-22-005590 001-37937 221157871 34 294560 1 1
2022-08-11 10-Q FORM 10-Q 0001683168-22-005567 001-37937 221156778 34 3392937 1 1
2022-07-07 8-K CURRENT REPORT 1.01,7.01,9.01 0001683168-22-004819 001-37937 221070716 34 283909 1 1
2022-06-06 8-K CURRENT REPORT 3.01 0001683168-22-004180 001-37937 22998446 34 249493 1 1
2022-05-12 10-Q FORM 10-Q 0001683168-22-003503 001-37937 22917775 34 2204878 1 1
2022-05-04 D xslFormDX01/primary_doc.xml 06b 0001200876-22-000025 021-444330 22889905 33 12775
2022-04-28 10-K/A AMENDMENT NO. 1 0001683168-22-003011 001-37937 22867084 34 243784
2022-04-27 8-K FORM 8-K 1.01,2.01,3.02,7.01,9.01 0001683168-22-002961 001-37937 22856203 34 299427 1 1
2022-03-28 4 xslF345X03/ownership.xml 0001683168-22-002000 5584
2022-03-28 4 xslF345X03/ownership.xml 0001683168-22-002002 5609
2022-03-28 4 xslF345X03/ownership.xml 0001683168-22-002001 5587
2022-03-23 8-K FORM 8-K 2.02,9.01 0001683168-22-001853 001-37937 22761647 34 279167 1 1
2022-03-22 10-K FORM 10-K 0001683168-22-001839 001-37937 22760726 34 6350757 1 1
2021-12-30 S-8 FORM S-8 0001683168-21-006669 333-261956 211533194 33 89849
2021-12-09 4 xslF345X03/ownership.xml 0001683168-21-006234 5343
2021-12-09 4 xslF345X03/ownership.xml 0001683168-21-006231 5375
2021-12-09 4 xslF345X03/ownership.xml 0001683168-21-006230 5307
2021-12-09 4 xslF345X03/ownership.xml 0001683168-21-006229 5324
2021-12-09 4 xslF345X03/ownership.xml 0001683168-21-006228 5325
2021-12-09 8-K CURRENT REPORT 5.07 0001683168-21-006223 001-37937 211482628 34 253357 1 1
2021-12-02 DEFA14A DEFINITIVE ADDITIONAL INFORMATION 0001683168-21-006069 001-37937 211466971 34 434586
2021-11-19 8-K FORM 8-K 1.01,9.01 0001683168-21-005860 001-37937 211429020 34 542926 1 1
2021-11-19 424B5 424B5 0001683168-21-005858 333-260201 211429005 33 405331
2021-11-16 8-K FORM 8-K 1.01,9.01 0001683168-21-005746 001-37937 211414185 34 297033 1 1
2021-11-12 8-K CURRENT REPORT 2.02,9.01 0001683168-21-005470 001-37937 211399681 34 282916 1 1
2021-11-12 10-Q FORM 10-Q 0001683168-21-005469 001-37937 211399633 34 2959979 1 1
2021-10-22 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2021-10-22 17:00:00 9999999995-21-004007 333-260201 211342035 33 1892
2021-10-20 CORRESP filename1.htm 0001683168-21-004953 12006
2021-10-20 S-3/A AMENDMENT TO FORM S-3 0001683168-21-004951 333-260201 211334515 33 378695
2021-10-19 UPLOAD filename1.pdf 0000000000-21-012610 40379
2021-10-15 DEF 14A DEFINITIVE PROXY 0001683168-21-004867 001-37937 211326561 34 620418
2021-10-15 8-K FORM 8-K 1.01,1.02 0001683168-21-004865 001-37937 211326366 34 248635 1 1
2021-10-12 S-3 REGISTRATION STATEMENT 0001683168-21-004784 333-260201 211319444 33 1379502
2021-09-13 8-K CURRENT REPORT 7.01,9.01 0001683168-21-004238 001-37937 211248582 34 8003244 1 1
2021-08-23 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2021-08-23 17:00:00 9999999995-21-003284 333-258810 211198377 33 1892
2021-08-19 CORRESP filename1.htm 0001683168-21-003789 11150
2021-08-18 UPLOAD filename1.pdf 0000000000-21-010160 40374
2021-08-13 S-3 FORM S-3 0001683168-21-003581 333-258810 211172643 33 206185
2021-08-13 8-K CURRENT REPORT 2.02,9.01 0001683168-21-003522 001-37937 211169795 34 293219 1 1
2021-08-12 10-Q FORM 10-Q FOR JUNE 30, 2021 0001683168-21-003464 001-37937 211168068 34 2721792 1 1
2021-08-03 D xslFormDX01/primary_doc.xml 06b 0001200876-21-000006 021-408666 211139383 33 13442
2021-07-28 8-K FORM 8-K 1.01,3.02,7.01 0001683168-21-003133 001-37937 211121905 34 719759
2021-07-16 8-K FORM 8-K 5.02 0001683168-21-002995 001-37937 211095763 34 20620
2021-05-12 8-K FORM 8-K 2.02,9.01 0001683168-21-001899 001-37937 21913413 34 51499
2021-05-11 10-Q FORM 10-Q 0001683168-21-001893 001-37937 21912239 34 1735132 1
2021-04-28 10-K/A FORM 10-K AMENDMENT 0001683168-21-001582 001-37937 21865134 34 250853
2021-03-22 4 xslF345X03/ownership.xml 0001683168-21-001019 5609
2021-03-22 4 xslF345X03/ownership.xml 0001683168-21-001018 5584
2021-03-22 4 xslF345X03/ownership.xml 0001683168-21-001020 5587
2021-03-17 8-K FORM 8-K 2.02,9.01 0001683168-21-000975 001-37937 21748462 34 50555
2021-03-16 10-K ANNUAL REPORT 0001683168-21-000969 001-37937 21746931 34 5392645 1
2021-01-19 8-K FORM 8-K 7.01,9.01 0001683168-21-000175 001-37937 21533964 34 6608129
2020-12-21 SC 13G SCHEDULE 13G 0001213900-20-043658 005-89709 201402336 34 65770
2020-12-16 8-K CURRENT REPORT 8.01 0001683168-20-004303 001-37937 201391393 34 20201
2020-12-14 8-K CURRENT REPORT 1.01,8.01,9.01 0001683168-20-004279 001-37937 201385442 34 355114
2020-12-11 424B5 PROSPECTUS SUPPLEMENT 0001683168-20-004276 333-227572 201384474 33 407250
2020-12-09 8-K FORM 8-K 5.07 0001683168-20-004225 001-37937 201378417 34 33510
2020-12-08 4 xslF345X03/ownership.xml 0001683168-20-004207 5386
2020-12-08 4 xslF345X03/ownership.xml 0001683168-20-004206 5319
2020-12-08 4 xslF345X03/ownership.xml 0001683168-20-004205 5307
2020-12-08 4 xslF345X03/ownership.xml 0001683168-20-004204 5324
2020-12-08 4 xslF345X03/ownership.xml 0001683168-20-004203 5325
2020-11-13 8-K FORM 8-K 2.02,9.01 0001683168-20-003880 001-37937 201309197 34 61215
2020-11-12 10-Q FORM 10-Q 0001683168-20-003871 001-37937 201307989 34 2278258 1
2020-10-30 8-K FORM 8-K 3.01 0001683168-20-003619 001-37937 201278039 34 24522
2020-10-14 UPLOAD filename1.pdf 0000000000-20-009710 39966
2020-10-13 DEF 14A DEFINITIVE PROXY 0001683168-20-003429 001-37937 201236667 34 586847
2020-10-06 CORRESP filename1.htm 0001683168-20-003372 13980
2020-10-05 UPLOAD filename1.pdf 0000000000-20-009367 43050
2020-09-30 PRE 14A PRELIMINARY PROXY STATEMENT 0001683168-20-003318 001-37937 201212765 34 586479
2020-08-13 8-K FORM 8-K 2.02,9.01 0001683168-20-002655 001-37937 201097173 34 61421
2020-08-12 10-Q QUARTERLY REPORT 0001683168-20-002645 001-37937 201095808 34 2364055 1
2020-06-24 8-K FORM 8-K 8.01 0001683168-20-002051 001-37937 20983936 34 16572
2020-06-16 8-K FORM 8-K 1.01,7.01,9.01 0001683168-20-001954 001-37937 20965011 34 59354
2020-05-19 8-K FORM 8-K 1.01,7.01,9.01 0001683168-20-001661 001-37937 20891584 34 47266
2020-05-14 10-Q QUARTERLY REPORT 0001683168-20-001566 001-37937 20877776 34 1697058 1
2020-05-14 8-K CURRENT REPORT 2.02,9.01 0001683168-20-001564 001-37937 20877711 34 48676
2020-04-29 10-K/A AMENDMENT NO. 1 0001683168-20-001321 001-37937 20830837 34 220318
2020-04-24 8-K CURRENT REPORT 3.01 0001683168-20-001278 001-37937 20815460 34 25200
2020-04-02 4/A xslF345X03/ownership.xml 0001683168-20-001069 4686
2020-04-01 S-8 FORMS-8 0001683168-20-001062 333-237529 20765862 33 94688
2020-03-27 8-K FORM 8-K 2.02,9.01 0001683168-20-000973 001-37937 20748215 34 50777
2020-03-26 10-K FORM 10-K 0001683168-20-000967 001-37937 20746920 34 5100709 1
2020-02-14 SC 13G/A SC 13G/A 0001193125-20-038180 005-89709 20619484 34 117836
2020-02-13 SC 13G/A AMENDMENT TO FORM SC 13G 0001387131-20-001537 005-89709 20610513 34 116834
2020-02-10 SC 13G/A SC 13G/A 0001104659-20-013384 005-89709 20591575 34 86699
2020-01-21 SC 13G/A XENETIC BIOSCIENCES, INC. 0000902664-20-000308 005-89709 20535646 34 66891
2020-01-13 SC 13G/A SABBY 13G-A XBIO 1.13.20 0001535610-20-000031 005-89709 20523763 34 13379
2019-12-06 4 xslF345X03/ownership.xml 0001683168-19-003923 5648
2019-12-06 4 xslF345X03/ownership.xml 0001683168-19-003921 5358
2019-12-06 4 xslF345X03/ownership.xml 0001683168-19-003919 5626
2019-12-06 4 xslF345X03/ownership.xml 0001683168-19-003917 5304
2019-12-06 4 xslF345X03/ownership.xml 0001683168-19-003915 5623
2019-12-06 4 xslF345X03/ownership.xml 0001683168-19-003913 5363
2019-12-06 4 xslF345X03/ownership.xml 0001683168-19-003911 5364
2019-12-06 8-K FORM 8-K 5.07 0001683168-19-003909 001-37937 191273803 34 31532
2019-11-15 8-K FORM 8-K 2.02,9.01 0001683168-19-003668 001-37937 191222526 34 288186 1 1
2019-11-14 10-Q FORM 10-Q 0001683168-19-003653 001-37937 191221717 34 2365867 1
2019-11-08 DEF 14A NOTICE AND PROXY STATEMENT 0001683168-19-003504 001-37937 191204437 34 639312
2019-10-23 SC 13D/A SC 13D/A 0000944809-19-000072 005-89709 191163999 34 67494
2019-10-08 8-K CURRENT REPORT 7.01,9.01 0001683168-19-003199 001-37937 191141826 34 54790
2019-09-30 4 xslF345X03/ownership.xml 0001683168-19-003107 5387
2019-09-30 4 xslF345X03/ownership.xml 0001683168-19-003106 5370
2019-09-30 3 xslF345X02/ownership.xml 0001683168-19-003105 8645
2019-09-30 8-K FORM 8-K 5.02 0001683168-19-003103 001-37937 191126764 34 21929
2019-09-23 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2019-09-23 16:00:00 9999999995-19-002156 333-233769 191109108 33 1892
2019-09-19 CORRESP filename1.htm 0001683168-19-002980 6305
2019-09-19 UPLOAD filename1.pdf 0000000000-19-013737 46108
2019-09-13 S-3 FORM S-3 REGISTRATION STATEMENT 0001683168-19-002928 333-233769 191093268 33 180846
2019-09-09 8-K FORM 8-K 7.01,9.01 0001683168-19-002876 001-37937 191081647 34 2591939
2019-09-04 SC 13G SABBY 13G XBIO 9.04.19 0001535610-19-000095 005-89709 191073758 34 13395
2019-08-15 8-K FORM 8-K 2.02,9.01 0001683168-19-002648 001-37937 191028470 34 59579
2019-08-14 10-Q FORM 10-Q 0001683168-19-002639 001-37937 191027611 34 1964714 1
2019-08-07 SC 13G SC 13G 0001104659-19-044521 005-89709 191005327 34 103244
2019-08-05 3 xslF345X02/ownership.xml 0001683168-19-002423 4307
2019-07-29 SC 13D SC 13D 0000944809-19-000050 005-89709 19981468 34 127502
2019-07-29 SC 13G SC 13G 0001193125-19-204659 005-89709 19979300 34 127569
2019-07-25 SC 13G ACQUISITION OF BENEFICIAL OWNERSHIP 0001387131-19-005343 005-89709 19975034 34 127877
2019-07-23 4 xslF345X03/ownership.xml 0001683168-19-002304 11940
2019-07-22 8-K FORM 8-K 1.01,3.02,5.02,8.01,9.01 0001683168-19-002278 001-37937 19966439 34 956120
2019-07-22 CERT 8A_Cert_XBIOW.pdf 0001354457-19-000362 001-37937 19965856 34 161090
2019-07-22 8-A12B FORM 8-A 0001683168-19-002273 001-37937 19965660 34 21941
2019-07-19 424B5 FORM 424B5 0001683168-19-002248 333-231508 19962214 33 1592612
2019-07-18 D xslFormDX01/primary_doc.xml 06b 0001683168-19-002236 021-344619 19961304 33 11722
2019-07-17 8-K FORM 8-K 8.01,9.01 0001683168-19-002217 001-37937 19958313 34 45966
2019-07-16 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2019-07-16 17:20:00 9999999995-19-001611 333-231508 19958165 33 1891
2019-07-16 8-K FORM 8-K 9.01 0001683168-19-002214 001-37937 19957699 34 92852
2019-07-16 8-K FORM 8-K 1.01,9.01 0001683168-19-002198 001-37937 19955877 34 46294
2019-07-15 CORRESP filename1.htm 0001683168-19-002192 7823
2019-07-15 CORRESP filename1.htm 0001683168-19-002189 6266
2019-07-12 S-1/A AMENDMENT NO. 5 0001683168-19-002183 333-231508 19953553 33 1870531
2019-07-12 CORRESP filename1.htm 0001683168-19-002177 5479
2019-07-12 CORRESP filename1.htm 0001683168-19-002176 5248
2019-07-10 CORRESP filename1.htm 0001683168-19-002146 7771
2019-07-10 CORRESP filename1.htm 0001683168-19-002145 6161
2019-07-05 S-1/A AMENDMENT NO. 4 0001683168-19-002118 333-231508 19943084 33 1683893
2019-07-03 CORRESP filename1.htm 0001683168-19-002122 7780
2019-07-03 CORRESP filename1.htm 0001683168-19-002120 5964
2019-07-02 S-1/A AMENDMENT NO. 3 0001683168-19-002077 333-231508 19935137 33 5979267 1
2019-07-02 8-K CURRENT REPORT 3.01 0001683168-19-002076 001-37937 19935120 34 19146
2019-06-25 8-K FORM 8-K 1.01,3.02,9.01 0001683168-19-002001 001-37937 19917126 34 207188
2019-06-24 8-K FORM 8-K 1.01,3.03,5.03,5.07 0001683168-19-001995 001-37937 19916205 34 98763
2019-06-24 S-1/A AMENDMENT NO. 2 TO FORM S-1 0001683168-19-001987 333-231508 19913661 33 1934404
2019-06-18 425 FILING PURSUANT TO RULE 425 0001683168-19-001926 001-37937 19902703 34 9814560
2019-06-13 8-K FORM 8-K 1.01,8.01,9.01 0001683168-19-001891 001-37937 19896832 34 56971
2019-06-13 425 FORM 8-K 0001683168-19-001892 001-37937 19896815 34 57562
2019-05-24 CORRESP filename1.htm 0001683168-19-001726 21422
2019-05-24 S-1/A AMENDMENT NO. 1 TO FORM S-1 0001683168-19-001725 333-231508 19855382 33 1604637
2019-05-22 EFFECT xslEFFECTX01/primary_doc.xml S-4,,2019-05-22 16:00:00 9999999995-19-001174 333-230637 19847863 33 1891
2019-05-22 424B3 FORM 424(B)(3) 0001683168-19-001695 333-230637 19846546 33 3365070
2019-05-21 UPLOAD filename1.pdf 0000000000-19-008782 50736
2019-05-21 CORRESP filename1.htm 0001683168-19-001667 6113
2019-05-20 S-4/A FORM S-4 AMENDMENT 0001683168-19-001643 333-230637 19838573 33 7211560 1
2019-05-20 8-K/A FORM 8-K AMENDMENT 8.01,9.01 0001683168-19-001640 001-37937 19838500 34 440299
2019-05-20 425 FORM 8-K AMENDMENT 0001683168-19-001641 001-37937 19838494 34 440946
2019-05-15 S-1 FORM S-1 REGISTRATION STATEMENT 0001683168-19-001583 333-231508 19828463 33 5369958 1
2019-05-13 S-4/A AMENDED REGISTRATION STATEMENT 0001683168-19-001494 333-230637 19819019 33 7251886 1
2019-05-13 8-K/A FORM 8-K AMENDMENT 8.01,9.01 0001683168-19-001480 001-37937 19817035 34 1135703
2019-05-13 425 FORM 8-K AMENDMENT 0001683168-19-001481 001-37937 19817031 34 1136350
2019-05-13 425 425 0001683168-19-001479 001-37937 19816925 34 41316
2019-05-13 8-K FORM 8-K 2.02,9.01 0001683168-19-001478 001-37937 19816920 34 65927
2019-05-13 10-Q FORM 10-Q 0001683168-19-001471 001-37937 19816321 34 1709150 1
2019-04-30 10-K/A FORM 10-K AMENDMENT NO. 1 0001683168-19-001259 001-37937 19782414 34 223896
2019-04-24 CORRESP filename1.htm 0001683168-19-001179 28924
2019-04-12 UPLOAD filename1.pdf 0000000000-19-007093 49007
2019-04-01 425 PROSPECTUS SUPPLEMENT 0001683168-19-000870 001-37937 19718800 34 33106
2019-03-29 S-4 REGISTRATION STATEMENT 0001683168-19-000852 333-230637 19717809 33 6321388 1
2019-03-29 10-K ANNUAL REPORT 0001683168-19-000840 001-37937 19717473 34 4290613 1
2019-03-20 CT ORDER filename1.pdf 20190320,20190320 9999999997-19-001661 001-37937 19695111 34 91183
2019-03-11 SC 13G XENETIC BIOSCIENCES, INC 0000902664-19-001458 005-89709 19672276 34 105452
2019-03-07 8-K FORM 8-K 1.01,3.02,9.01 0001683168-19-000576 001-37937 19666846 34 596728
2019-03-07 424B5 PROSPECTUS SUPPLEMENT 0001683168-19-000575 333-227572 19666840 33 487684
2019-03-07 425 FORM 8-K 0001683168-19-000577 001-37937 19666829 34 597292
2019-03-07 D xslFormDX01/primary_doc.xml 06b 0001683168-19-000573 021-334343 19666769 33 13004
2019-03-05 8-K FORM 8-K 8.01,9.01 0001683168-19-000547 001-37937 19656852 34 46894
2019-03-05 425 FORM 8-K 0001683168-19-000548 001-37937 19656849 34 47547
2019-03-04 8-K FORM 8-K 1.01,3.02,8.01,9.01 0001683168-19-000534 001-37937 19651997 34 4384054
2019-03-04 425 FORM 8-K 0001683168-19-000535 001-37937 19651991 34 4384586
2019-01-31 4 xslF345X03/ownership.xml 0001662252-19-000014 4827
2018-11-30 4 xslF345X03/ownership.xml 0001662252-18-000107 13192
2018-11-30 4 xslF345X03/ownership.xml 0001662252-18-000106 13197
2018-11-30 4 xslF345X03/ownership.xml 0001662252-18-000105 5386
2018-11-30 4 xslF345X03/ownership.xml 0001662252-18-000104 13160
2018-11-30 8-K FORM 8-K 5.07 0001683168-18-003591 001-37937 181211755 34 30167
2018-11-13 DEF 14A DEF 14A 0001683168-18-003379 001-37937 181179045 34 346623
2018-11-09 10-Q QUARTERLY REPORT 0001683168-18-003331 001-37937 181173494 34 1455636 1
2018-10-12 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2018-10-12 10:00:00 9999999995-18-002611 333-227572 181121193 33 1892
2018-10-09 CORRESP filename1.htm 0001683168-18-003002 11313
2018-10-05 UPLOAD filename1.pdf 0000000000-18-031540 46224
2018-09-27 S-3 FORM S-3 REGISTRATION STATEMENT 0001683168-18-002876 333-227572 181091876 33 1328955
2018-08-10 10-Q FORM 10-Q 0001683168-18-002256 001-37937 181009250 34 1413795 1
2018-05-15 10-Q QUARTERLY REPORT 0001683168-18-001382 001-37937 18837028 34 1312079 1
2018-05-03 CT ORDER filename1.pdf 20180503,20180503 9999999997-18-005482 001-37937 18803304 34 16542
2018-04-30 10-K/A AMENDMENT NO. 1 0001683168-18-001121 001-37937 18790248 34 221232
2018-03-30 10-K FORM 10-K 0001683168-18-000831 001-37937 18726376 34 5345412 1
2017-12-22 S-8 FORM S-8 0001683168-17-003385 333-222272 171273144 33 108319
2017-11-17 4 OWNERSHIP DOCUMENT 0001662252-17-000232 13725
2017-11-17 4 OWNERSHIP DOCUMENT 0001662252-17-000230 13689
2017-11-17 8-K FORM 8-K 5.07 0001683168-17-003084 001-37937 171211336 34 25162
2017-11-15 8-K FORM 8-K 2.02,9.01 0001683168-17-003049 001-37937 171203848 34 103921
2017-11-14 10-Q FORM 10-Q 0001683168-17-003031 001-37937 171202167 34 1810808 1
2017-11-03 8-K FORM 8-K 5.02 0001683168-17-002834 001-37937 171177276 34 20462
2017-11-03 DEFR14A REVISED DEFINITIVE PROXY STATEMENT 0001683168-17-002822 001-37937 171174670 34 600191
2017-11-02 8-K CURRENT REPORT 1.01,8.01,9.01 0001683168-17-002801 001-37937 171170809 34 43971
2017-11-01 8-K FORM 8-K 5.02,8.01,9.01 0001683168-17-002796 001-37937 171169890 34 50269
2017-10-30 4 OWNERSHIP DOCUMENT 0001662252-17-000220 8147
2017-10-27 3 PRIMARY DOCUMENT 0001711456-17-000005 6327
2017-10-27 3 PRIMARY DOCUMENT 0001711454-17-000003 15466
2017-10-13 4 OWNERSHIP DOCUMENT 0001662252-17-000209 12254
2017-10-13 4 OWNERSHIP DOCUMENT 0001662252-17-000207 12262
2017-10-02 8-K FORM 8-K 8.01 0001683168-17-002533 001-37937 171113401 34 18948
2017-09-12 3 OWNERSHIP DOCUMENT 0001662252-17-000191 6264
2017-08-29 3 OWNERSHIP DOCUMENT 0001662252-17-000177 3658
2017-08-23 4 OWNERSHIP DOCUMENT 0001662252-17-000171 3095
2017-08-23 8-K FORM 8-K 8.01 0001683168-17-002202 001-37937 171046188 34 19603
2017-08-22 4 OWNERSHIP DOCUMENT 0001662252-17-000169 3089
2017-08-22 3 OWNERSHIP DOCUMENT 0001662252-17-000167 11734
2017-08-15 8-K FORM 8-K 2.02,9.01 0001683168-17-002137 001-37937 171032441 34 98422
2017-08-14 10-Q FORM 10-Q 0001683168-17-002122 001-37937 171031483 34 1642784 1
2017-08-14 8-K FORM 8-K 3.01,5.02,9.01 0001683168-17-002120 001-37937 171031311 34 48089
2017-07-18 8-K 8-K 8.01 0001662252-17-000143 001-37937 17969673 34 14429
2017-07-13 SC 13D SC 13D 0001193125-17-227377 005-89709 17962954 34 120676
2017-06-22 DEF 14A DEFINITIVE PROXY 0001683168-17-001647 001-37937 17925746 34 656235
2017-06-15 3/A OWNERSHIP DOCUMENT 0001662252-17-000128 12712
2017-06-15 3/A OWNERSHIP DOCUMENT 0001662252-17-000126 13724
2017-06-15 3/A OWNERSHIP DOCUMENT 0001662252-17-000125 13724
2017-06-15 4/A OWNERSHIP DOCUMENT 0001662252-17-000123 18638
2017-06-15 3/A OWNERSHIP DOCUMENT 0001662252-17-000121 16043
2017-06-15 4/A OWNERSHIP DOCUMENT 0001662252-17-000119 20768
2017-06-15 3/A OWNERSHIP DOCUMENT 0001662252-17-000117 13784
2017-06-09 PRE 14A PRELIMINARY PROXY 0001683168-17-001538 001-37937 17903177 34 656323
2017-05-22 8-K FORM 8-K 7.01,9.01 0001683168-17-001351 001-37937 17859640 34 43953
2017-05-16 S-8 FORM S-8 0001683168-17-001279 333-218024 17846741 33 108506
2017-05-15 10-Q QUARTERLY REPORT 0001683168-17-001272 001-37937 17845508 34 1515175 1
2017-05-02 DEF 14C DEF 14C 0001662252-17-000100 001-37937 17804768 34 261285
2017-05-01 10-K/A AMENDED ANNUAL REPORT 0001683168-17-001066 001-37937 17800877 34 266189
2017-04-27 8-K FORM 8-K 5.02,5.08 0001683168-17-001028 001-37937 17789245 34 19854
2017-04-04 4 FORM 4 SUBMISSION 0001209191-17-024356 5710
2017-04-04 3 FORM 3 SUBMISSION 0001209191-17-024355 3146
2017-04-04 8-K FORM 8-K 3.02,5.02,7.01,9.01 0001683168-17-000786 001-37937 17736211 34 287653
2017-03-31 10-K FORM 10-K 0001683168-17-000749 001-37937 17731265 34 5608209 1
2017-03-22 PRE 14C PRE 14C 0001662252-17-000054 001-37937 17706303 34 223078
2017-02-27 8-K 8-K 5.03,9.01 0001662252-17-000027 001-37937 17641512 34 176738
2017-01-06 3 OWNERSHIP DOCUMENT 0001662252-17-000007 14385
2017-01-04 8-K 8-K 5.02,7.01,8.01,9.01 0001662252-17-000005 001-37937 17507131 34 796726
2016-12-23 4 OWNERSHIP DOCUMENT 0001662252-16-000305 10211
2016-12-23 4 OWNERSHIP DOCUMENT 0001662252-16-000303 8410
2016-12-23 4 OWNERSHIP DOCUMENT 0001662252-16-000301 12275
2016-12-23 4 OWNERSHIP DOCUMENT 0001662252-16-000299 12234
2016-12-06 8-K 8-K 5.02,7.01,9.01 0001662252-16-000278 001-37937 162037041 34 286078
2016-12-06 4 OWNERSHIP DOCUMENT 0001662252-16-000276 12234
2016-11-30 3 OWNERSHIP DOCUMENT 0001662252-16-000271 3661
2016-11-22 SC 13D SC 13D 0001662252-16-000267 005-89709 162013155 34 59655
2016-11-22 3 OWNERSHIP DOCUMENT 0001662252-16-000265 8398
2016-11-22 8-K 8-K 5.02,7.01,9.01 0001662252-16-000263 001-37937 162013021 34 217031
2016-11-21 3 OWNERSHIP DOCUMENT 0001662252-16-000261 6051
2016-11-21 3 OWNERSHIP DOCUMENT 0001662252-16-000259 3639
2016-11-21 3 OWNERSHIP DOCUMENT 0001662252-16-000255 5052
2016-11-15 3 OWNERSHIP DOCUMENT 0001662252-16-000253 6095
2016-11-15 3 OWNERSHIP DOCUMENT 0001662252-16-000252 3553
2016-11-14 10-Q 10-Q 0001683168-16-000646 001-37937 161995992 34 1746679 1
2016-11-03 424B4 PROSPECTUS SUPPLEMENT 0001683168-16-000468 333-211249 161971377 33 1924001
2016-11-01 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2016-11-01 16:00:00 9999999995-16-006118 333-211249 161966190 33 1892
2016-11-01 CERTNAS AUTO-GENERATED PAPER DOCUMENT 9999999997-16-026601 001-37937 16005135 34 1497
2016-11-01 8-A12B/A FORM 8-A12B 0001683168-16-000433 001-37937 161964031 34 12538
2016-11-01 8-A12B FORM 8-A12B 0001683168-16-000431 001-37937 161963729 34 12307
2016-10-31 CORRESP filename1.htm 0001683168-16-000423 10321
2016-10-31 CORRESP filename1.htm 0001683168-16-000422 13807
2016-10-31 S-1/A FORM S-1 AMENDMENT 0001683168-16-000421 333-211249 161962117 33 7151771 1
2016-10-28 CORRESP filename1.htm 0001683168-16-000406 13856
2016-10-28 CORRESP filename1.htm 0001683168-16-000405 6467
2016-10-27 S-1/A FORM S-1 AMENDMENT 0001683168-16-000392 333-211249 161954907 33 195196
2016-10-27 S-1/A FORM S-1 AMENDMENT 0001683168-16-000384 333-211249 161953427 33 7000935 1
2016-10-26 CORRESP filename1.htm 0001683168-16-000387 10032
2016-10-26 CORRESP filename1.htm 0001683168-16-000386 14935
2016-10-26 CORRESP filename1.htm 0001683168-16-000385 6729
2016-10-24 CORRESP filename1.htm 0001683168-16-000365 14485
2016-10-24 CORRESP filename1.htm 0001683168-16-000364 9674
2016-10-21 S-1/A FORM S-1 AMENDMENT 0001683168-16-000354 333-211249 161946762 33 6935911 1
2016-10-11 CORRESP filename1.htm 0001683168-16-000281 25185
2016-10-11 S-1/A AMENDMENT TO S-1 REGISTRATION STATEMENT 0001683168-16-000280 333-211249 161929525 33 7433062 1
2016-10-05 UPLOAD filename1.pdf 0000000000-16-095920 145729

Latest XBRL company facts

One latest value per concept from companyfacts (343 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 2.34M 2026-11-06 2026 Q3 10-Q 2026-11-12 0001683168-26-008628
dei EntityPublicFloat Entity Public Float USD 5.11M 2025-06-30 2025 FY 10-K/A 2026-04-24 0001683168-26-003207
us-gaap AccountsAndOtherReceivablesNetCurrent Accounts and Other Receivables, Net, Current USD 0 2015-09-30 2015 Q3 10-Q 2015-11-16 0001019687-15-004147
us-gaap AccountsPayableAndAccruedLiabilitiesCurrent Accounts Payable and Accrued Liabilities, Current USD 609,532 2020-12-31 2020 FY 10-K 2021-03-16 0001683168-21-000969
us-gaap AccountsPayableAndOtherAccruedLiabilitiesCurrent Accounts Payable and Other Accrued Liabilities, Current USD 496,181 2026-09-30 2026 Q3 10-Q 2026-11-12 0001683168-26-008628
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 1.41M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001683168-26-008628
us-gaap AccountsReceivableGrossCurrent Accounts Receivable, before Allowance for Credit Loss, Current USD 130,258 2012-12-31 2013 FY 10-K 2015-07-20 0001019687-15-002805
us-gaap AccountsReceivableNetCurrent Accounts Receivable, after Allowance for Credit Loss, Current USD 0 2017-12-31 2017 FY 10-K 2018-03-30 0001683168-18-000831
us-gaap AccretionExpense Accretion Expense USD 0 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-30 0001683168-18-000831
us-gaap AccruedBonusesCurrent Accrued Bonuses, Current USD 422,226 2013-12-31 2013 FY 10-K 2015-07-20 0001019687-15-002805
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 709,916 2025-12-31 2025 FY 10-K 2026-03-12 0001683168-26-001737
us-gaap AccruedPayrollTaxesCurrent Accrued Payroll Taxes, Current USD 84,599 2013-12-31 2013 FY 10-K 2015-07-20 0001019687-15-002805
us-gaap AccruedProfessionalFeesCurrent Accrued Professional Fees, Current USD 215,056 2025-12-31 2025 FY 10-K 2026-03-12 0001683168-26-001737
us-gaap AccumulatedAmortizationDeferredFinanceCosts Accumulated Amortization, Debt Issuance Costs USD 0 2016-12-31 2016 FY 10-K 2017-03-31 0001683168-17-000749
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 0 2022-12-31 2022 FY 10-K 2023-03-22 0001683168-23-001674
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipmentPeriodIncreaseDecrease Accumulated Depreciation, Depletion and Amortization, Property, Plant and Equipment, Period Increase (Decrease) USD 18,283 2013-09-01 2013-11-30 2014 Q1 10-Q 2014-01-10 0001504167-14-000015
us-gaap AccumulatedDepreciationDepletionAndAmortizationWritedownOfPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Write-down of Property, Plant and Equipment (Deprecated 2013-01-31) USD 35,420 2011-08-09 2013-05-31 2013 Q3 10-Q 2013-07-17 0001255294-13-000560
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD 253,734 2026-09-30 2026 Q3 10-Q 2026-11-12 0001683168-26-008628
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 212.40M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001683168-26-008628
us-gaap AdjustmentOfWarrantsGrantedForServices Adjustment of Warrants Granted for Services USD -26,576 2019-01-01 2019-03-31 2019 Q1 10-Q 2019-05-13 0001683168-19-001471
us-gaap AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature USD 4.04M 2016-01-01 2016-12-31 2017 FY 10-K 2018-03-30 0001683168-18-000831
us-gaap AdjustmentsToAdditionalPaidInCapitalOther Adjustments to Additional Paid in Capital, Other USD 47,427 2019-01-01 2019-12-31 2020 FY 10-K 2021-03-16 0001683168-21-000969
us-gaap AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition APIC, Share-based Payment Arrangement, ESPP, Increase for Cost Recognition USD 1.35M 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-29 0001683168-19-000840
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 99,298 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001683168-26-008628
us-gaap AdjustmentsToAdditionalPaidInCapitalStockSplit Adjustments to Additional Paid in Capital, Stock Split USD -63,536 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-26 0001683168-20-000967
us-gaap AdjustmentsToAdditionalPaidInCapitalWarrantIssued Adjustments to Additional Paid in Capital, Warrant Issued USD 2.07M 2016-01-01 2016-12-31 2017 FY 10-K 2018-03-30 0001683168-18-000831
us-gaap AdministrativeFeesExpense Administrative Fees Expense USD 45 2013-09-01 2013-11-30 2014 Q1 10-Q 2014-01-10 0001504167-14-000015
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 100,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001683168-26-001737
us-gaap AllowanceForDoubtfulAccountsReceivable Accounts Receivable, Allowance for Credit Loss USD 0 2013-12-31 2013 FY 10-K 2015-07-20 0001019687-15-002805
us-gaap AmortizationOfDebtDiscountPremium Amortization of Debt Discount (Premium) USD 0 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-30 0001683168-18-000831
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 29,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001683168-26-001737
us-gaap AssetImpairmentCharges Asset Impairment Charges USD 700,000 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-12 0001683168-26-001737
us-gaap Assets Assets USD 6.32M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001683168-26-008628
us-gaap AssetsCurrent Assets, Current USD 6.00M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001683168-26-008628
us-gaap BusinessAcquisitionCostOfAcquiredEntityTransactionCosts Business Acquisition, Transaction Costs USD 3.00M 2014-01-23 2014 Q3 10-Q 2014-11-14 0001193125-14-413225
us-gaap BusinessAcquisitionSharePrice Business Acquisition, Share Price GBP 0.06 2014-01-23 2014 Q3 10-Q 2014-11-14 0001193125-14-413225
us-gaap BusinessCombinationAcquisitionRelatedCosts Business Combination, Acquisition Related Costs USD 2.20M 2013-01-01 2013-12-31 2013 FY 10-K 2015-07-20 0001019687-15-002805
us-gaap BusinessCombinationConsiderationTransferred1 Business Combination, Consideration Transferred USD 3.75M 2014-01-23 2014 Q3 10-Q 2014-11-14 0001193125-14-413225
us-gaap BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable Business Combination, Consideration Transferred, Equity Interests Issued and Issuable USD 0 2015-01-01 2015-12-31 2015 FY 10-K 2016-03-30 0001019687-16-005662
us-gaap BusinessCombinationIntegrationRelatedCosts Business Combination, Integration Related Costs USD 50,000 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-18 0001683168-25-001686
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents USD 43,502 2014-01-23 2014 Q3 10-Q 2014-11-14 0001193125-14-413225
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Prepaid Expense and Other Assets USD 8,643 2014-01-23 2014 Q3 10-Q 2014-11-14 0001193125-14-413225
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables USD 145 2014-01-23 2014 Q3 10-Q 2014-11-14 0001193125-14-413225
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable USD 354,079 2014-01-23 2014 Q3 10-Q 2014-11-14 0001193125-14-413225
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLongTermDebt Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Long-term Debt USD 372,813 2014-01-23 2014 Q3 10-Q 2014-11-14 0001193125-14-413225
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Other USD 36,146 2014-01-23 2014 Q3 10-Q 2014-11-14 0001193125-14-413225
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net USD -379,248 2014-01-23 2014 Q3 10-Q 2014-11-14 0001193125-14-413225
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment USD 331,500 2014-01-23 2014 Q3 10-Q 2014-11-14 0001193125-14-413225
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net USD 3.75M 2014-01-23 2014 Q3 10-Q 2014-11-14 0001193125-14-413225
us-gaap Cash Cash USD 7.35M 2026-03-31 2026 Q1 10-Q 2026-05-12 0001683168-26-003727
us-gaap CashAcquiredFromAcquisition Cash Acquired from Acquisition USD 0 2015-01-01 2015-12-31 2015 FY 10-K 2016-03-30 0001019687-16-005662
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 5.81M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001683168-26-008628
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect USD -2.07M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001683168-26-008628
us-gaap CashDivestedFromDeconsolidation Cash Divested from Deconsolidation USD 0 2015-01-01 2015-12-31 2015 FY 10-K 2016-03-30 0001019687-16-005662
us-gaap CashEquivalentsAtCarryingValue Cash Equivalents, at Carrying Value USD 0 2013-11-30 2014 Q1 10-Q 2014-01-10 0001504167-14-000015
us-gaap CashFDICInsuredAmount Cash, FDIC Insured Amount USD 250,000 2023-09-30 2023 Q3 10-Q 2023-11-09 0001683168-23-007820
us-gaap CashPeriodIncreaseDecrease Cash, Period Increase (Decrease) USD 1.48M 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-30 0001683168-18-000831
us-gaap ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 Class of Warrant or Right, Exercise Price of Warrants or Rights USD/shares 29.09 2025-12-31 2026 Q3 10-Q 2026-11-12 0001683168-26-008628
us-gaap ClassOfWarrantOrRightOutstanding Class of Warrant or Right, Outstanding shares 800 2025-12-31 2026 Q3 10-Q 2026-11-12 0001683168-26-008628
us-gaap CommitmentsAndContingencies Commitments and Contingencies USD 0 2024-03-31 2024 Q1 10-Q 2024-05-09 0001683168-24-003172
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0.001 2026-09-30 2026 Q3 10-Q 2026-11-12 0001683168-26-008628
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 10.00M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001683168-26-008628
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 2.35M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001683168-26-008628
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 2.34M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001683168-26-008628
us-gaap CommonStockValue Common Stock, Value, Issued USD 2,346 2026-09-30 2026 Q3 10-Q 2026-11-12 0001683168-26-008628
us-gaap CompensatingBalanceAmount Compensating Balance, Amount USD 0 2019-12-31 2019 FY 10-K 2020-03-26 0001683168-20-000967
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD -3.60M 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-30 0001683168-18-000831
us-gaap ConcentrationRiskPercentage1 Concentration Risk, Percentage pure 1 2012-01-01 2012-12-31 2013 FY 10-K 2015-07-20 0001019687-15-002805
us-gaap ContractsRevenue Contracts Revenue (Deprecated 2018-01-31) USD 0 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-30 0001683168-18-000831
us-gaap ContractualObligation Contractual Obligation USD 1,000 2017-09-30 2017 Q3 10-Q 2017-11-14 0001683168-17-003031
us-gaap CostOfRevenue Cost of Revenue USD 0 2018-01-01 2018-09-30 2018 Q3 10-Q 2018-11-09 0001683168-18-003331
us-gaap CostOfServices Cost of Services (Deprecated 2018-01-31) USD 59,091 2017-01-01 2017-06-30 2017 Q2 10-Q 2017-08-14 0001683168-17-002122
us-gaap CostsIncurredDevelopmentCosts Costs Incurred, Development Costs USD 156,119 2017-01-01 2017-09-30 2017 Q3 10-Q 2017-11-14 0001683168-17-003031
us-gaap CurrentFederalTaxExpenseBenefit Current Federal Tax Expense (Benefit) USD -831,658 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-18 0001683168-25-001686
us-gaap CurrentStateAndLocalTaxExpenseBenefit Current State and Local Tax Expense (Benefit) USD -311,694 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-18 0001683168-25-001686
us-gaap DebtInstrumentConvertibleConversionPrice1 Debt Instrument, Convertible, Conversion Price USD/shares 0.15 2015-09-30 2015 Q3 10-Q 2015-11-16 0001019687-15-004147
us-gaap DebtInstrumentFaceAmount Debt Instrument, Face Amount USD 3.00M 2015-09-30 2015 Q3 10-Q 2015-11-16 0001019687-15-004147
us-gaap DebtIssuanceCosts Debt Issuance Cost (Deprecated 2016-01-31) USD 16,769 2015-01-01 2015-12-31 2015 FY 10-K 2016-03-30 0001019687-16-005662
us-gaap DeferredCreditsAndOtherLiabilitiesCurrent Deferred Credits and Other Liabilities, Current USD 6,703 2018-09-30 2018 Q3 10-Q 2018-11-09 0001683168-18-003331
us-gaap DeferredIncomeTaxesAndTaxCredits Deferred Income Taxes and Tax Credits USD 0 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-12 0001683168-21-005469
us-gaap DeferredIncomeTaxLiabilities Deferred Tax Liabilities, Gross USD 0 2025-12-31 2025 FY 10-K 2026-03-12 0001683168-26-001737
us-gaap DeferredIncomeTaxLiabilitiesNet Deferred Income Tax Liabilities, Net USD 27,043 2020-12-31 2021 FY 10-K 2022-03-22 0001683168-22-001839
us-gaap DeferredRentCredit Deferred Rent Credit USD 77,147 2014-09-30 2014 Q3 10-Q 2014-11-14 0001193125-14-413225
us-gaap DeferredTaxAssetsCapitalLossCarryforwards Deferred Tax Assets, Capital Loss Carryforwards USD 1.26M 2016-12-31 2016 FY 10-K 2017-03-31 0001683168-17-000749
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 39.79M 2025-12-31 2025 FY 10-K 2026-03-12 0001683168-26-001737
us-gaap DeferredTaxAssetsInProcessResearchAndDevelopment Deferred Tax Assets, in Process Research and Development USD 534,753 2025-12-31 2025 FY 10-K 2026-03-12 0001683168-26-001737
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 0 2025-12-31 2025 FY 10-K 2026-03-12 0001683168-26-001737
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsDomestic Deferred Tax Assets, Operating Loss Carryforwards, Domestic USD 8.13M 2025-12-31 2025 FY 10-K 2026-03-12 0001683168-26-001737
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal Deferred Tax Assets, Operating Loss Carryforwards, State and Local USD 2.76M 2025-12-31 2025 FY 10-K 2026-03-12 0001683168-26-001737
us-gaap DeferredTaxAssetsOther Deferred Tax Assets, Other USD 0 2023-12-31 2023 FY 10-K 2024-03-21 0001683168-24-001594
us-gaap DeferredTaxAssetsPropertyPlantAndEquipment Deferred Tax Assets, Property, Plant and Equipment USD 151,294 2025-12-31 2025 FY 10-K 2026-03-12 0001683168-26-001737
us-gaap DeferredTaxAssetsTaxCreditCarryforwardsResearch Deferred Tax Assets, Tax Credit Carryforwards, Research USD 2.28M 2025-12-31 2025 FY 10-K 2026-03-12 0001683168-26-001737
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost USD 429,581 2025-12-31 2025 FY 10-K 2026-03-12 0001683168-26-001737
us-gaap DeferredTaxAssetsTaxDeferredExpenseOther Deferred Tax Assets, Tax Deferred Expense, Other USD 1.66M 2025-12-31 2025 FY 10-K 2026-03-12 0001683168-26-001737
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Other USD 91,118 2020-12-31 2020 FY 10-K 2021-03-16 0001683168-21-000969
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 40.70M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001683168-26-008628
us-gaap DeferredTaxLiabilities Deferred Tax Liabilities, Net USD 0 2025-12-31 2025 FY 10-K 2026-03-12 0001683168-26-001737
us-gaap DeferredTaxLiabilitiesGoodwillAndIntangibleAssets Deferred Tax Liabilities, Goodwill and Intangible Assets USD 3.26M 2013-12-31 2013 FY 10-K 2015-07-20 0001019687-15-002805
us-gaap DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets Deferred Tax Liabilities, Intangible Assets USD 0 2020-12-31 2020 FY 10-K 2021-03-16 0001683168-21-000969
us-gaap DeferredTaxLiabilitiesLeasingArrangements Deferred Tax Liabilities, Leasing Arrangements USD 0 2023-12-31 2023 FY 10-K 2024-03-21 0001683168-24-001594
us-gaap DeferredTaxLiabilitiesNoncurrent Deferred Tax Liabilities, Net, Noncurrent USD 2.92M 2020-06-30 2020 Q2 10-Q 2020-08-12 0001683168-20-002645
us-gaap DeferredTaxLiabilitiesOther Deferred Tax Liabilities, Other USD 0 2018-12-31 2018 FY 10-K 2019-03-29 0001683168-19-000840
us-gaap DepositsAssetsNoncurrent Deposits Assets, Noncurrent USD 66,000 2018-09-30 2018 Q3 10-Q 2018-11-09 0001683168-18-003331
us-gaap Depreciation Depreciation USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-22 0001683168-22-001839
us-gaap DepreciationAndAmortization Depreciation, Depletion and Amortization, Nonproduction USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-22 0001683168-23-001674
us-gaap DepreciationDepletionAndAmortization Depreciation, Depletion and Amortization USD 27,246 2016-01-01 2016-09-30 2016 Q3 10-Q 2016-11-14 0001683168-16-000646
us-gaap DerivativeFairValueOfDerivativeLiability Derivative Liability, Fair Value, Gross Liability USD 2.80M 2015-09-30 2015 Q3 10-Q 2015-11-16 0001019687-15-004147
us-gaap DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) USD 240,989 2013-05-31 2013 Q3 10-Q 2013-07-17 0001255294-13-000560
us-gaap DueToRelatedPartiesCurrent Due to Related Parties, Current USD 0 2016-12-31 2016 FY 10-K 2017-03-31 0001683168-17-000749
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -1.33 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001683168-26-008628
us-gaap EarningsPerShareBasicAndDiluted Earnings Per Share, Basic and Diluted USD/shares -0.55 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-22 0001683168-22-001839
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -1.33 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001683168-26-008628
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001683168-26-001737
us-gaap EffectOfExchangeRateOnCashAndCashEquivalents Effect of Exchange Rate on Cash and Cash Equivalents USD 0 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-31 0001683168-17-000749
us-gaap EmployeeBenefitsAndShareBasedCompensation Employee Benefits and Share-based Compensation USD 64,787 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001683168-26-001737
us-gaap EmployeeRelatedLiabilitiesCurrent Employee-related Liabilities, Current USD 84,475 2025-12-31 2025 FY 10-K 2026-03-12 0001683168-26-001737
us-gaap EquipmentExpense Equipment Expense USD 12,000 2012-09-01 2012-11-30 2014 Q1 10-Q 2014-01-10 0001504167-14-000015
us-gaap FairValueAdjustmentOfWarrants Fair Value Adjustment of Warrants USD -100,000 2017-01-01 2017-09-30 2017 Q3 10-Q 2017-11-14 0001683168-17-003031
us-gaap FairValueAssumptionsRiskFreeInterestRate Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31) pure 0.005 2016-01-01 2016-09-30 2017 Q3 10-Q 2017-11-14 0001683168-17-003031
us-gaap FairValueAssumptionsWeightedAverageVolatilityRate Fair Value Assumptions, Weighted Average Volatility Rate (Deprecated 2018-01-31) pure 1.05 2016-01-01 2016-09-30 2017 Q3 10-Q 2017-11-14 0001683168-17-003031
us-gaap FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Gain (Loss) Included in Earnings USD -1.34M 2015-01-01 2015-09-30 2015 Q3 10-Q 2015-11-16 0001019687-15-004147
us-gaap FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationIssues Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Issues USD 1.42M 2015-01-01 2015-09-30 2015 Q3 10-Q 2015-11-16 0001019687-15-004147
us-gaap FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis with Unobservable Inputs USD 0 2018-12-31 2018 FY 10-K 2019-03-29 0001683168-19-000840
us-gaap FinanceLeaseRightOfUseAsset Finance Lease, Right-of-Use Asset, after Accumulated Amortization USD 0 2022-09-30 2022 Q3 10-Q 2022-11-09 0001683168-22-007447
us-gaap FinanceLeaseRightOfUseAssetAmortization Finance Lease, Right-of-Use Asset, Amortization USD 16,629 2019-01-01 2019-09-30 2019 Q3 10-Q 2019-11-14 0001683168-19-003653
us-gaap FinancialInstrumentsOwnedAtFairValue Financial Instruments, Owned, at Fair Value USD 0 2026-09-30 2026 Q3 10-Q 2026-11-12 0001683168-26-008628
us-gaap ForeignCurrencyTransactionGainBeforeTax Foreign Currency Transaction Gain, before Tax USD 0 2016-01-01 2016-09-30 2016 Q3 10-Q 2016-11-14 0001683168-16-000646
us-gaap ForeignCurrencyTransactionGainLossBeforeTax Foreign Currency Transaction Gain (Loss), before Tax USD 0 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-31 0001683168-17-000749
us-gaap FutureMinimumSubleaseRentalsSaleLeasebackTransactions Future Minimum Sublease Rentals, Sale Leaseback Transactions USD 52,000 2019-09-30 2019 Q3 10-Q 2019-11-14 0001683168-19-003653
us-gaap GainLossOnRepurchaseOfDebtInstrument Gain (Loss) on Repurchase of Debt Instrument USD -1.69M 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-31 0001683168-17-000749
us-gaap GainLossOnSaleOfBusiness Gain (Loss) on Disposition of Business USD 0 2015-01-01 2015-12-31 2015 FY 10-K 2016-03-30 0001019687-16-005662
us-gaap GainLossOnSaleOfPropertyPlantEquipment Gain (Loss) on Disposition of Property Plant Equipment USD 0 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-16 0001683168-21-000969
us-gaap GainLossRelatedToLitigationSettlement Gain (Loss) Related to Litigation Settlement USD 10,668 2012-09-01 2013-08-31 2013 FY 10-K 2013-11-27 0001255294-13-000958
us-gaap GainsLossesOnExtinguishmentOfDebt Gain (Loss) on Extinguishment of Debt USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-22 0001683168-22-001839
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 3.67M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001683168-26-008628
us-gaap Goodwill Goodwill USD 0 2020-12-31 2021 FY 10-K 2022-03-22 0001683168-22-001839
us-gaap GoodwillAcquiredDuringPeriod Goodwill, Acquired During Period USD 0 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-26 0001683168-20-000967
us-gaap GoodwillAndIntangibleAssetImpairment Goodwill and Intangible Asset Impairment USD 3.28M 2019-01-01 2019-09-30 2019 Q3 10-Q 2019-11-14 0001683168-19-003653
us-gaap GoodwillForeignCurrencyTranslationGainLoss Goodwill, Foreign Currency Translation Gain (Loss) USD -181,778 2015-01-01 2015-12-31 2016 FY 10-K 2017-03-31 0001683168-17-000749
us-gaap GoodwillImpairmentLoss Goodwill, Impairment Loss USD 9.24M 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-22 0001683168-22-001839
us-gaap GoodwillPeriodIncreaseDecrease Goodwill, Period Increase (Decrease) USD 0 2019-01-01 2019-09-30 2019 Q3 10-Q 2019-11-14 0001683168-19-003653
us-gaap GoodwillTranslationAdjustments Goodwill, Translation Adjustments (Deprecated 2016-01-31) USD -181,778 2015-01-01 2015-12-31 2015 FY 10-K 2016-03-30 0001019687-16-005662
us-gaap GoodwillWrittenOffRelatedToSaleOfBusinessUnit Goodwill, Written off Related to Sale of Business Unit USD 4.13M 2014-01-01 2014-12-31 2015 FY 10-K 2016-03-30 0001019687-16-005662
us-gaap GrossProfit Gross Profit USD 1.00M 2013-01-01 2013-12-31 2013 FY 10-K 2015-07-20 0001019687-15-002805
us-gaap HybridInstrumentsAtFairValueNet Hybrid Instruments at Fair Value, Net USD 2.80M 2015-09-30 2015 Q3 10-Q 2015-11-16 0001019687-15-004147
us-gaap ImpairmentOfIntangibleAssetsExcludingGoodwill Impairment of Intangible Assets (Excluding Goodwill) USD 0 2018-01-01 2018-09-30 2018 Q3 10-Q 2018-11-09 0001683168-18-003331
us-gaap ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) USD -9.24M 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-16 0001683168-21-000969
us-gaap ImpairmentOfLongLivedAssetsHeldForUse Impairment of Long-Lived Assets Held-for-use USD 0 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-16 0001683168-21-000969
us-gaap IncomeLossFromContinuingOperations Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent USD -82,462 2013-09-01 2013-11-30 2014 Q1 10-Q 2014-01-10 0001504167-14-000015
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD -3.80M 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-12 0001683168-21-005469
us-gaap IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet Income (Loss) from Continuing Operations before Interest Expense, Interest Income, Income Taxes, Noncontrolling Interests, Net USD -5.65M 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-22 0001683168-22-001839
us-gaap IncomeTaxesPaidNet Income Taxes Paid, Net USD 0 2015-01-01 2015-03-31 2015 Q1 10-Q 2015-05-20 0001019687-15-002064
us-gaap IncomeTaxExaminationPenaltiesAndInterestAccrued Income Tax Examination, Penalties and Interest Accrued USD 0 2025-12-31 2025 FY 10-K 2026-03-12 0001683168-26-001737
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001683168-26-008628
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD 1.46M 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-18 0001683168-25-001686
us-gaap IncomeTaxReconciliationChangeInEnactedTaxRate Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-21 0001683168-24-001594
us-gaap IncomeTaxReconciliationForeignIncomeTaxRateDifferential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount USD 80,187 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-18 0001683168-25-001686
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD 562,981 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001683168-26-001737
us-gaap IncomeTaxReconciliationNondeductibleExpense Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount USD 122,683 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-18 0001683168-25-001686
us-gaap IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses Effective Income Tax Rate Reconciliation, Nondeductible Expense, Impairment Losses, Amount USD 0 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-16 0001683168-21-000969
us-gaap IncomeTaxReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount USD 1.88M 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-26 0001683168-20-000967
us-gaap IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount USD 6,495 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-18 0001683168-25-001686
us-gaap IncomeTaxReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Amount USD -389,984 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-18 0001683168-25-001686
us-gaap IncomeTaxReconciliationOtherReconcilingItems Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount USD 163 2013-01-01 2013-12-31 2013 FY 10-K 2015-07-20 0001019687-15-002805
us-gaap IncomeTaxReconciliationTaxCredits Effective Income Tax Rate Reconciliation, Tax Credit, Amount USD 51,292 2013-01-01 2013-12-31 2013 FY 10-K 2015-07-20 0001019687-15-002805
us-gaap IncomeTaxReconciliationTaxCreditsForeign Effective Income Tax Rate Reconciliation, Tax Credit, Foreign, Amount USD 1.99M 2013-01-01 2013-12-31 2013 FY 10-K 2015-07-20 0001019687-15-002805
us-gaap IncomeTaxReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount USD -139,259 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-18 0001683168-25-001686
us-gaap IncreaseDecreaseInAccountsAndOtherReceivables Increase (Decrease) in Accounts and Other Receivables USD -255,660 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001683168-26-001737
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD -121,055 2013-09-01 2013-11-30 2014 Q1 10-Q 2014-01-10 0001504167-14-000015
us-gaap IncreaseDecreaseInAccountsPayableAndAccruedLiabilities Increase (Decrease) in Accounts Payable and Accrued Liabilities USD 936,021 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001683168-26-008628
us-gaap IncreaseDecreaseInAccountsReceivable Increase (Decrease) in Accounts Receivable USD 0 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-29 0001683168-19-000840
us-gaap IncreaseDecreaseInDeferredIncomeTaxes Increase (Decrease) in Deferred Income Taxes USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-22 0001683168-22-001839
us-gaap IncreaseDecreaseInDerivativeLiabilities Increase (Decrease) in Derivative Liabilities USD 1.30M 2015-01-01 2015-09-30 2015 Q3 10-Q 2015-11-16 0001019687-15-004147
us-gaap IncreaseDecreaseInInterestPayableNet Increase (Decrease) in Interest Payable, Net USD 5,695 2013-09-01 2013-11-30 2014 Q1 10-Q 2014-01-10 0001504167-14-000015
us-gaap IncreaseDecreaseInOperatingCapital Increase (Decrease) in Operating Capital USD -2.50M 2020-01-01 2020-09-30 2020 Q3 10-Q 2020-11-12 0001683168-20-003871
us-gaap IncreaseDecreaseInOtherNoncurrentAssets Increase (Decrease) in Other Noncurrent Assets USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001683168-26-008628
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD 27,761 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001683168-26-008628
us-gaap IncreaseDecreaseInPrepaidExpense Increase (Decrease) in Prepaid Expense USD 491 2013-09-01 2013-11-30 2014 Q1 10-Q 2014-01-10 0001504167-14-000015
us-gaap IncreaseDecreaseInRestrictedCash Increase (Decrease) in Restricted Cash USD 66,000 2013-01-01 2013-12-31 2013 FY 10-K 2015-07-20 0001019687-15-002805
us-gaap IncreaseDecreaseInRestrictedCashAndInvestmentsForOperatingActivities Increase (Decrease) in Restricted Investments for Operating Activities USD 0 2014-01-01 2014-12-31 2014 FY 10-K 2015-04-15 0001019687-15-001465
us-gaap IndefiniteLivedIntangibleAssetsExcludingGoodwill Indefinite-lived Intangible Assets (Excluding Goodwill) USD 0 2020-12-31 2020 FY 10-K 2021-03-16 0001683168-21-000969
us-gaap InterestAndOtherIncome Interest and Other Income USD 126,709 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001683168-26-008628
us-gaap InterestExpense Interest Expense USD 1,818 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-30 0001683168-18-000831
us-gaap InterestExpenseDebt Interest Expense, Debt USD 690,000 2016-01-01 2016-09-30 2017 Q3 10-Q 2017-11-14 0001683168-17-003031
us-gaap InterestExpenseOther Interest Expense, Other USD 130,408 2015-01-01 2015-09-30 2015 Q3 10-Q 2015-11-16 0001019687-15-004147
us-gaap InterestIncomeExpenseNet Interest Income (Expense), Net USD 147,997 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001683168-26-001737
us-gaap InterestIncomeOther Interest Income, Other USD 16,544 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-30 0001683168-18-000831
us-gaap InterestPaid Interest Paid, Including Capitalized Interest, Operating and Investing Activities USD 1,100 2017-01-01 2017-06-30 2017 Q2 10-Q 2017-08-14 0001683168-17-002122
us-gaap InterestPaidNet Interest Paid, Excluding Capitalized Interest, Operating Activities USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001683168-26-008628
us-gaap InterestPayableCurrent Interest Payable, Current USD 0 2016-12-31 2016 FY 10-K 2017-03-31 0001683168-17-000749
us-gaap InvestmentIncomeInterest Investment Income, Interest USD 87,823 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-06 0001683168-26-006061
us-gaap LeaseAndRentalExpense Operating Leases, Rent Expense USD 128,606 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-31 0001683168-17-000749
us-gaap LeaseCost Lease, Cost USD 16,629 2019-01-01 2019-09-30 2019 Q3 10-Q 2019-11-14 0001683168-19-003653
us-gaap LesseeOperatingLeaseDiscountRate Lessee, Operating Lease, Discount Rate pure 0.102 2020-09-30 2020 Q3 10-Q 2020-11-12 0001683168-20-003871
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 78,000 2020-09-30 2020 Q3 10-Q 2020-11-12 0001683168-20-003871
us-gaap LettersOfCreditOutstandingAmount Letters of Credit Outstanding, Amount USD 200,000 2025-12-31 2025 FY 10-K 2026-03-12 0001683168-26-001737
us-gaap Liabilities Liabilities USD 1.90M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001683168-26-008628
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 6.32M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001683168-26-008628
us-gaap LiabilitiesCurrent Liabilities, Current USD 1.90M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001683168-26-008628
us-gaap LiabilitiesOtherThanLongtermDebtNoncurrent Liabilities, Other than Long-term Debt, Noncurrent USD 27,043 2020-12-31 2021 Q3 10-Q 2021-11-12 0001683168-21-005469
us-gaap LiabilityForUncertainTaxPositionsCurrent Liability for Uncertainty in Income Taxes, Current USD 0 2025-12-31 2025 FY 10-K 2026-03-12 0001683168-26-001737
us-gaap LicenseAndServicesRevenue License and Services Revenue (Deprecated 2018-01-31) USD 0 2017-01-01 2017-09-30 2017 Q3 10-Q 2017-11-14 0001683168-17-003031
us-gaap LicensesRevenue Licenses Revenue (Deprecated 2018-01-31) USD 7.50M 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-30 0001683168-18-000831
us-gaap LineOfCredit Long-term Line of Credit USD 160,000 2013-11-30 2014 Q1 10-Q 2014-01-10 0001504167-14-000015
us-gaap LitigationSettlementAmountAwardedToOtherParty Litigation Settlement, Amount Awarded to Other Party USD 700,000 2017-01-01 2017-09-30 2017 Q3 10-Q 2017-11-14 0001683168-17-003031
us-gaap LongTermDebtCurrent Long-term Debt, Current Maturities USD 372,813 2013-11-30 2014 Q1 10-Q 2014-01-10 0001504167-14-000015
us-gaap LongTermDebtNoncurrent Long-term Debt, Excluding Current Maturities USD 212,813 2013-08-31 2013 FY 10-K 2013-11-27 0001255294-13-000958
us-gaap LongTermDebtPercentageBearingFixedInterestRate Long-term Debt, Percentage Bearing Fixed Interest, Percentage Rate pure 0.06 2016-08-31 2013 Q3 10-Q 2013-07-17 0001255294-13-000560
us-gaap ManagementFeeExpense Management Fee Expense USD 7,752 2012-09-01 2012-11-30 2014 Q1 10-Q 2014-01-10 0001504167-14-000015
us-gaap MaterialsSuppliesAndOther Materials, Supplies, and Other USD 700,000 2018-12-31 2018 FY 10-K 2019-03-29 0001683168-19-000840
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 4.00M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001683168-26-001737
us-gaap NetCashProvidedByUsedInFinancingActivitiesContinuingOperations Net Cash Provided by (Used in) Financing Activities, Continuing Operations USD 0 2017-01-01 2017-06-30 2017 Q2 10-Q 2017-08-14 0001683168-17-002122
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-21 0001683168-24-001594
us-gaap NetCashProvidedByUsedInInvestingActivitiesContinuingOperations Net Cash Provided by (Used in) Investing Activities, Continuing Operations USD -9,264 2017-01-01 2017-06-30 2017 Q2 10-Q 2017-08-14 0001683168-17-002122
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -2.07M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001683168-26-008628
us-gaap NetCashProvidedByUsedInOperatingActivitiesContinuingOperations Net Cash Provided by (Used in) Operating Activities, Continuing Operations USD -1.71M 2017-01-01 2017-06-30 2017 Q2 10-Q 2017-08-14 0001683168-17-002122
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -3.08M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001683168-26-008628
us-gaap NetIncomeLossAvailableToCommonStockholdersBasic Net Income (Loss) Available to Common Stockholders, Basic USD -10.89M 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-16 0001683168-21-000969
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD 131,404 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001683168-26-008628
us-gaap NotesAndLoansPayableCurrent Notes and Loans Payable, Current USD 212,813 2013-11-30 2014 Q1 10-Q 2014-01-10 0001504167-14-000015
us-gaap NumberOfOperatingSegments Number of Operating Segments Integer 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001683168-26-008628
us-gaap NumberOfReportableSegments Number of Reportable Segments Integer 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001683168-26-008628
us-gaap OfficersCompensation Salary and Wage, Officer, Excluding Cost of Good and Service Sold USD 15,000 2012-09-01 2013-08-31 2013 FY 10-K 2013-11-27 0001255294-13-000958
us-gaap OperatingCostsAndExpenses Operating Costs and Expenses USD 23,168 2012-09-01 2013-05-31 2013 Q3 10-Q 2013-07-17 0001255294-13-000560
us-gaap OperatingExpenses Operating Expenses USD 5.41M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001683168-26-008628
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -3.21M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001683168-26-008628
us-gaap OperatingLeaseExpense Operating Lease, Expense USD 100,000 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-29 0001683168-19-000840
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 71,000 2020-10-02 2020 Q3 10-Q 2020-11-12 0001683168-20-003871
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 0 2023-06-30 2023 Q2 10-Q 2023-08-10 0001683168-23-005513
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 0 2022-09-30 2022 Q3 10-Q 2022-11-09 0001683168-22-007447
us-gaap OperatingLeasePayments Operating Lease, Payments USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-21 0001683168-24-001594
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 0 2023-06-30 2023 Q2 10-Q 2023-08-10 0001683168-23-005513
us-gaap OperatingLeaseRightOfUseAssetAmortizationExpense Operating Lease, Right-of-Use Asset, Amortization Expense USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-21 0001683168-24-001594
us-gaap OperatingLeasesFutureMinimumPaymentsDue Operating Leases, Future Minimum Payments Due USD 3,000 2019-09-30 2019 Q3 10-Q 2019-11-14 0001683168-19-003653
us-gaap OperatingLeasesFutureMinimumPaymentsDueCurrent Operating Leases, Future Minimum Payments Due, Next Twelve Months USD 24,583 2018-12-31 2018 FY 10-K 2019-03-29 0001683168-19-000840
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFiveYears Operating Leases, Future Minimum Payments, Due in Five Years USD 106,563 2013-12-31 2013 FY 10-K 2015-07-20 0001019687-15-002805
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFourYears Operating Leases, Future Minimum Payments, Due in Four Years USD 8,908 2015-12-31 2015 FY 10-K 2016-03-30 0001019687-16-005662
us-gaap OperatingLeasesFutureMinimumPaymentsDueInThreeYears Operating Leases, Future Minimum Payments, Due in Three Years USD 8,908 2016-12-31 2016 FY 10-K 2017-03-31 0001683168-17-000749
us-gaap OperatingLeasesFutureMinimumPaymentsDueInTwoYears Operating Leases, Future Minimum Payments, Due in Two Years USD 0 2018-12-31 2018 FY 10-K 2019-03-29 0001683168-19-000840
us-gaap OperatingLeasesFutureMinimumPaymentsDueThereafter Operating Leases, Future Minimum Payments, Due Thereafter USD 8,908 2013-12-31 2013 FY 10-K 2015-07-20 0001019687-15-002805
us-gaap OperatingLeasesRentExpenseNet Operating Leases, Rent Expense, Net USD 100,000 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-30 0001683168-18-000831
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 23,875 2025-12-31 2025 FY 10-K 2026-03-12 0001683168-26-001737
us-gaap OtherAssetImpairmentCharges Other Asset Impairment Charges USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-22 0001683168-22-001839
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 313,921 2026-09-30 2026 Q3 10-Q 2026-11-12 0001683168-26-008628
us-gaap OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax USD 0 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-31 0001683168-17-000749
us-gaap OtherCostAndExpenseOperating Other Cost and Expense, Operating USD 3.02M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001683168-26-001737
us-gaap OtherDepreciationAndAmortization Other Depreciation and Amortization USD 26,199 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-12 0001683168-21-005469
us-gaap OtherExpenses Other Expenses USD 26,414 2016-01-01 2016-03-31 2016 Q1 10-Q 2016-05-16 0001019687-16-006322
us-gaap OtherGeneralExpense Other General Expense USD 45,000 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-18 0001683168-25-001686
us-gaap OtherIncome Other Income USD 1,122 2021-01-01 2021-06-30 2021 Q2 10-Q 2021-08-12 0001683168-21-003464
us-gaap OtherLiabilitiesCurrent Other Liabilities, Current USD 538,734 2019-09-30 2019 Q3 10-Q 2019-11-14 0001683168-19-003653
us-gaap OtherLiabilitiesNoncurrent Other Liabilities, Noncurrent USD 6,178 2019-06-30 2019 Q2 10-Q 2019-08-14 0001683168-19-002639
us-gaap OtherNoncashExpense Other Noncash Expense USD 0 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-30 0001683168-18-000831
us-gaap OtherNoncashIncome Other Noncash Income USD 129,743 2015-01-01 2015-09-30 2015 Q3 10-Q 2015-11-16 0001019687-15-004147
us-gaap OtherNoncashIncomeExpense Other Noncash Income (Expense) USD 0 2017-01-01 2017-09-30 2017 Q3 10-Q 2017-11-14 0001683168-17-003031
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD 4,695 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001683168-26-008628
us-gaap OtherPreferredStockDividendsAndAdjustments Other Preferred Stock Dividends and Adjustments USD 5.28M 2019-01-01 2019-12-31 2020 FY 10-K 2021-03-16 0001683168-21-000969
us-gaap OtherPrepaidExpenseCurrent Other Prepaid Expense, Current USD 200,000 2021-12-31 2021 FY 10-K 2022-03-22 0001683168-22-001839
us-gaap OtherResearchAndDevelopmentExpense Other Research and Development Expense USD 78,000 2023-03-16 2023-03-17 2023 FY 10-K 2024-03-21 0001683168-24-001594
us-gaap OtherSalesRevenueNet Other Revenue, Net (Deprecated 2018-01-31) USD 85,000 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-30 0001683168-18-000831
us-gaap OtherSignificantNoncashTransactionValueOfConsiderationGiven1 Other Significant Noncash Transaction, Value of Consideration Given USD -40,611 2016-01-01 2016-09-30 2016 Q3 10-Q 2016-11-14 0001683168-16-000646
us-gaap PaymentsForFees Payments for Other Fees USD 300,000 2022-07-01 2022-09-30 2022 Q3 10-Q 2022-11-09 0001683168-22-007447
us-gaap PaymentsForRestructuring Payments for Restructuring USD 430,000 2014-01-01 2014-12-31 2014 FY 10-K 2015-04-15 0001019687-15-001465
us-gaap PaymentsOfDebtIssuanceCosts Payments of Debt Issuance Costs USD 0 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-30 0001683168-18-000831
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 80,774 2012-01-01 2012-12-31 2013 FY 10-K 2015-07-20 0001019687-15-002805
us-gaap PaymentsToAcquireInProcessResearchAndDevelopment Payments to Acquire in Process Research and Development USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-21 0001683168-24-001594
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 0 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-29 0001683168-19-000840
us-gaap PreferredStockDividendsIncomeStatementImpact Preferred Stock Dividends, Income Statement Impact USD 0 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-16 0001683168-21-000969
us-gaap PreferredStockLiquidationPreferenceValue Preferred Stock, Liquidation Preference, Value USD 4 2016-09-30 2016 Q3 10-Q 2016-11-14 0001683168-16-000646
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0.001 2016-09-30 2016 Q3 10-Q 2016-11-14 0001683168-16-000646
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 10.00M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001683168-26-008628
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 970,000 2016-09-30 2016 Q3 10-Q 2016-11-14 0001683168-16-000646
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 970,000 2016-09-30 2016 Q3 10-Q 2016-11-14 0001683168-16-000646
us-gaap PreferredStockValue Preferred Stock, Value, Issued USD 2,774 2021-03-31 2021 Q1 10-Q 2021-05-11 0001683168-21-001893
us-gaap PrepaidExpenseAndOtherAssets Prepaid Expense and Other Assets USD 400,000 2023-12-31 2023 FY 10-K 2024-03-21 0001683168-24-001594
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 194,055 2026-09-30 2026 Q3 10-Q 2026-11-12 0001683168-26-008628
us-gaap PrepaidExpenseCurrent Prepaid Expense, Current USD 8,729 2013-11-30 2014 Q1 10-Q 2014-01-10 0001504167-14-000015
us-gaap PrepaidExpenseNoncurrent Prepaid Expense, Noncurrent USD 300,000 2022-09-30 2022 Q3 10-Q 2022-11-09 0001683168-22-007447
us-gaap PrepaidRent Prepaid Rent USD 32,000 2017-12-31 2017 FY 10-K 2018-03-30 0001683168-18-000831
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 4.00M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001683168-26-001737
us-gaap ProceedsFromIssuanceOfDebt Proceeds from Issuance of Debt USD 100,000 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-22 0001683168-22-001839
us-gaap ProceedsFromIssuanceOfPreferredStockPreferenceStockAndWarrants Proceeds from Issuance of Preferred Stock, Preference Stock, and Warrants USD 11.45M 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-12 0001683168-21-005469
us-gaap ProceedsFromIssuanceOfPrivatePlacement Proceeds from Issuance of Private Placement USD 11.50M 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-12 0001683168-21-005469
us-gaap ProceedsFromIssuanceOrSaleOfEquity Proceeds from Issuance or Sale of Equity USD 0 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-16 0001683168-21-000969
us-gaap ProceedsFromNotesPayable Proceeds from Notes Payable USD 100,000 2015-01-01 2015-06-30 2015 Q2 10-Q 2015-08-19 0001019687-15-003198
us-gaap ProceedsFromOtherEquity Proceeds from Other Equity USD 11.45M 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-22 0001683168-22-001839
us-gaap ProceedsFromSaleOfPropertyPlantAndEquipment Proceeds from Sale of Property, Plant, and Equipment USD 0 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-16 0001683168-21-000969
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 0 2015-01-01 2015-12-31 2015 FY 10-K 2016-03-30 0001019687-16-005662
us-gaap ProceedsFromWarrantExercises Proceeds from Warrant Exercises USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-22 0001683168-23-001674
us-gaap ProductionCosts Production Costs, Period Cost USD 11,936 2012-09-01 2012-11-30 2014 Q1 10-Q 2014-01-10 0001504167-14-000015
us-gaap ProfessionalFees Professional Fees USD 60,608 2013-09-01 2013-11-30 2014 Q1 10-Q 2014-01-10 0001504167-14-000015
us-gaap ProfitLoss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD -5.65M 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-22 0001683168-22-001839
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 0 2022-12-31 2022 FY 10-K 2023-03-22 0001683168-23-001674
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 0 2022-12-31 2022 FY 10-K 2023-03-22 0001683168-23-001674
us-gaap RelatedPartyCosts Related Party Costs USD 100,000 2021-01-01 2021-03-31 2021 Q1 10-Q 2021-05-11 0001683168-21-001893
us-gaap RepaymentsOfDebt Repayments of Debt USD 0 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-30 0001683168-18-000831
us-gaap RepaymentsOfRelatedPartyDebt Repayments of Related Party Debt USD 0 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-30 0001683168-18-000831
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 1.73M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001683168-26-008628
us-gaap ResearchAndDevelopmentInProcess Research and Development in Process USD 1.30M 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-09 0001683168-22-007447
us-gaap RestrictedCash Restricted Cash USD 200,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001683168-26-008628
us-gaap RestrictedCashAndCashEquivalents Restricted Cash and Cash Equivalents USD 0 2019-09-30 2019 Q3 10-Q 2019-11-14 0001683168-19-003653
us-gaap RestrictedCashAndCashEquivalentsAtCarryingValue Restricted Cash and Cash Equivalents, Current USD 66,000 2015-09-30 2015 Q3 10-Q 2015-11-16 0001019687-15-004147
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -202.96M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001683168-26-008628
us-gaap Revenues Revenues USD 2.19M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001683168-26-008628
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-22 0001683168-22-001839
us-gaap RoyaltyIncomeNonoperating Royalty Income, Nonoperating USD 2.98M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001683168-26-001737
us-gaap SalariesAndWages Salary and Wage, NonOfficer, Excluding Cost of Good and Service Sold USD 490,077 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001683168-26-008628
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 99,298 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001683168-26-008628
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period shares 0 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-12 0001683168-26-008628
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised shares 0 2025-07-01 2025-09-30 2026 Q3 10-Q 2026-11-12 0001683168-26-008628
us-gaap ShareBasedGoodsAndNonemployeeServicesTransactionModificationOfTermsIncrementalCompensationCost Share-based Goods and Nonemployee Services Transaction, Modification of Terms, Incremental Compensation Cost USD 25,008 2015-01-01 2015-12-31 2015 FY 10-K 2016-03-30 0001019687-16-005662
us-gaap SharePrice Share Price USD/shares 4.5 2016-12-31 2017 Q3 10-Q 2017-11-14 0001683168-17-003031
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 4.41M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001683168-26-008628
us-gaap StockholdersEquityNoteStockSplitConversionRatio1 Stockholders' Equity Note, Stock Split, Conversion Ratio pure 0.083 2019-01-01 2019-06-25 2020 Q3 10-Q 2020-11-12 0001683168-20-003871
us-gaap StockIssuedDuringPeriodSharesNewIssues Stock Issued During Period, Shares, New Issues shares 850,000 2022-10-01 2022-10-12 2022 Q3 10-Q 2022-11-09 0001683168-22-007447
us-gaap StockIssuedDuringPeriodSharesPeriodIncreaseDecrease Stock Issued During Period, Shares, Period Increase (Decrease) shares 1,442 2019-01-01 2019-06-25 2020 FY 10-K 2021-03-16 0001683168-21-000969
us-gaap StockIssuedDuringPeriodValueAcquisitions Stock Issued During Period, Value, Acquisitions USD 3.75M 2014-01-01 2014-12-31 2014 FY 10-K 2015-04-15 0001019687-15-001465
us-gaap StockIssuedDuringPeriodValueConversionOfConvertibleSecurities Stock Issued During Period, Value, Conversion of Convertible Securities USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001683168-26-008628
us-gaap StockIssuedDuringPeriodValueConversionOfUnits Stock Issued During Period, Value, Conversion of Units USD 1.48M 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-29 0001683168-19-000840
us-gaap StockIssuedDuringPeriodValueEmployeeStockPurchasePlan Stock Issued During Period, Value, Employee Stock Purchase Plan USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001683168-26-008628
us-gaap StockIssuedDuringPeriodValueIssuedForServices Stock Issued During Period, Value, Issued for Services USD 69,708 2018-01-01 2018-12-31 2019 FY 10-K 2020-03-26 0001683168-20-000967
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 4.00M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001683168-26-001737
us-gaap StockIssuedDuringPeriodValueOther Stock Issued During Period, Value, Other USD 0 2019-04-01 2019-06-30 2019 Q2 10-Q 2019-08-14 0001683168-19-002639
us-gaap StockIssuedDuringPeriodValuePurchaseOfAssets Stock Issued During Period, Value, Purchase of Assets USD 3.03M 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-26 0001683168-20-000967
us-gaap StockIssuedDuringPeriodValueShareBasedCompensation Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture USD 1.17M 2016-01-01 2016-12-31 2017 FY 10-K 2018-03-30 0001683168-18-000831
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 101,933 2014-01-01 2014-12-31 2015 FY 10-K 2016-03-30 0001019687-16-005662
us-gaap StockRepurchasedAndRetiredDuringPeriodValue Stock Repurchased and Retired During Period, Value USD 0 2015-01-01 2015-12-31 2015 FY 10-K 2016-03-30 0001019687-16-005662
us-gaap SuppliesExpense Supplies Expense USD 0 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-29 0001683168-19-000840
us-gaap TreasuryStockCommonValue Treasury Stock, Common, Value USD 5.28M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001683168-26-008628
us-gaap TreasuryStockValue Treasury Stock, Value USD 5.28M 2022-12-31 2022 FY 10-K 2023-03-22 0001683168-23-001674
us-gaap UnrealizedGainLossOnDerivatives Unrealized Gain (Loss) on Derivatives USD 0 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-30 0001683168-18-000831
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 0 2026-09-30 2026 Q3 10-Q 2026-11-12 0001683168-26-008628
us-gaap UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions Unrecognized Tax Benefits, Decrease Resulting from Current Period Tax Positions USD 0 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-30 0001683168-18-000831
us-gaap UnrecognizedTaxBenefitsDecreasesResultingFromForeignCurrencyTranslation Unrecognized Tax Benefits, Decrease Resulting from Foreign Currency Translation USD 3,710 2013-01-01 2013-12-31 2013 FY 10-K 2015-07-20 0001019687-15-002805
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions USD 0 2014-01-01 2014-12-31 2014 FY 10-K 2015-04-15 0001019687-15-001465
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromForeignCurrencyTranslation Unrecognized Tax Benefits, Increase Resulting from Foreign Currency Translation USD 0 2014-01-01 2014-12-31 2014 FY 10-K 2015-04-15 0001019687-15-001465
us-gaap ValuationAllowancesAndReservesAdjustments SEC Schedule, 12-09, Valuation Allowances and Reserves, Increase (Decrease) Adjustment USD -4.25M 2014-01-01 2014-12-31 2014 FY 10-K 2015-04-15 0001019687-15-001465
us-gaap ValuationAllowancesAndReservesBalance SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount USD 22.76M 2017-12-31 2017 FY 10-K 2018-03-30 0001683168-18-000831
us-gaap ValuationAllowancesAndReservesDeductions SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction USD 1.26M 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-30 0001683168-18-000831
us-gaap ValuationAllowancesAndReservesPeriodIncreaseDecrease SEC Schedule, 12-09, Valuation Allowances and Reserves, Period Increase (Decrease) USD 0 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-30 0001683168-18-000831
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 2.31M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001683168-26-008628
us-gaap WeightedAverageNumberOfShareOutstandingBasicAndDiluted Weighted Average Number of Shares Outstanding, Basic and Diluted shares 10.28M 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-22 0001683168-22-001839
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 2.31M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001683168-26-008628

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →